Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab
More than half of patients inadequately responding to OMA achieved a good prognosis 12 months later. Several clinical variables appear to be predictive of prognosis, and certain therapeutic agents can be associated with prognostic outcomes.
Authors
- Yukinobu Nakagawa (ORCID: https://orcid.org/0000-0002-8247-0385)
- Atsushi Fukunaga (ORCID: https://orcid.org/0000-0003-2026-8154)
- Shunsuke Takahagi (ORCID: https://orcid.org/0000-0001-9951-1342)
- Koremasa Hayama (ORCID: https://orcid.org/0000-0001-8651-2493)
- Yuko Chinuki (ORCID: https://orcid.org/0000-0001-6548-6038)
- Haruka Watanabe (ORCID: https://orcid.org/0000-0003-3084-6990)
- Naoko Inomata (ORCID: https://orcid.org/0000-0002-1989-9824)
- Michihiro Hide
Institutions
- Nihon University (JP)
- Hiroshima University (JP)
- SHOWA Medical University (JP)
- Shimane University (JP)
- Hiroshima General Hospital (JP)
- Hiroshima City Asa Citizens Hospital (JP)
- Kobe University (JP)
- Yokohama City University (JP)
- Osaka University of Pharmaceutical Sciences (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2024-11-03
- DOI
- https://doi.org/10.1111/ijd.17547
- Citations
- 2
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.94